Pediatric Hematology and Oncology, Johann Wolfgang Goethe-University, Theodor-Stern-Kai 7, Frankfurt, Germany.
J Immunol Methods. 2011 Oct 28;373(1-2):36-44. doi: 10.1016/j.jim.2011.07.018. Epub 2011 Aug 3.
Regulatory T cells (Tregs) are of crucial importance to suppress graft versus host disease (GvHD) post allogeneic stem cell transplantation (SCT), but are also known to impair antitumor immunity. However, Treg longitudinal studies are rare and in this respect advanced flowcytometric approaches for Treg characterization are necessary. To investigate the relation of both the percentage and the absolute numbers of Tregs on GvHD or relapse we measured CD4(+)CD25(+/hi)CD127(lo/-) Tregs in 239 peripheral blood (PB) samples of 16 patients during the first two years post-SCT. A 10-color flowcytometric panel was established to evaluate Treg subpopulations and has been tested in ten healthy individuals. In patients we demonstrated a decrease in CD127 expression on T cells early post-SCT which increases during the first year. Moreover, Tregs reached higher absolute numbers in patients with GvHD≤grade I compared to those with GvHD grades II-IV. In contrast, the percentage of Tregs was significantly higher in patients with GvHD grades II-IV or disease relapse compared to those without GvHD. These patients fit into the range of healthy individuals where a median value of 7.5% and 6.4% of T helper cells were characterized as CD4(+)CD25(+/hi)CD127(lo/-) and CD4(+)CD25(+/hi) Tregs, respectively. Furthermore, Tregs could be further subdivided into 40% naïve, 51% central memory and 9% effector memory Tregs. Our results showed for the first time a downregulation of CD127 expression on T cells including Tregs in patients early post-SCT. Additionally, new insights into the recovery of Tregs regarding GvHD and relapse were provided.
调节性 T 细胞(Tregs)对于抑制同种异体干细胞移植(SCT)后移植物抗宿主病(GvHD)至关重要,但也已知会损害抗肿瘤免疫。然而,Treg 的纵向研究很少,在这方面,先进的流式细胞术方法对于 Treg 特征分析是必要的。为了研究 Tregs 的百分比和绝对数量与 GvHD 或复发的关系,我们在 SCT 后两年内测量了 16 例患者的 239 个外周血(PB)样本中的 CD4(+)CD25(+/hi)CD127(lo/-)Tregs。建立了一个 10 色流式细胞术面板来评估 Treg 亚群,并在 10 名健康个体中进行了测试。在患者中,我们发现在 SCT 后早期 T 细胞上 CD127 的表达减少,在第一年增加。此外,与 GvHD 分级 II-IV 的患者相比,GvHD≤I 级的患者的 Tregs 绝对数量更高。相比之下,GvHD 分级 II-IV 或疾病复发的患者的 Treg 百分比明显高于无 GvHD 的患者。这些患者处于健康个体的范围内,其中中位数为 7.5%和 6.4%的辅助性 T 细胞分别被鉴定为 CD4(+)CD25(+/hi)CD127(lo/-)和 CD4(+)CD25(+/hi)Tregs。此外,Tregs 可以进一步分为 40%的幼稚型、51%的中央记忆型和 9%的效应记忆型 Tregs。我们的结果首次显示患者 SCT 后早期 T 细胞包括 Tregs 上 CD127 表达下调。此外,还提供了关于 GvHD 和复发的 Treg 恢复的新见解。